KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) FCF Margin (2016 - 2025)

AbbVie (ABBV) has disclosed FCF Margin for 14 consecutive years, with 29.42% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 1532.0% to 29.42% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 29.13% through Dec 2025, down 252.0% year-over-year, with the annual reading at 29.13% for FY2025, 252.0% down from the prior year.
  • FCF Margin for Q4 2025 was 29.42% at AbbVie, down from 42.11% in the prior quarter.
  • The five-year high for FCF Margin was 53.81% in Q3 2021, with the low at 10.49% in Q1 2025.
  • Average FCF Margin over 5 years is 36.2%, with a median of 34.35% recorded in 2021.
  • The sharpest move saw FCF Margin plummeted -3025bps in 2024, then soared 1763bps in 2025.
  • Over 5 years, FCF Margin stood at 32.84% in 2021, then soared by 45bps to 47.72% in 2022, then tumbled by -33bps to 31.8% in 2023, then soared by 41bps to 44.74% in 2024, then crashed by -34bps to 29.42% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 29.42%, 42.11%, and 31.67% for Q4 2025, Q3 2025, and Q2 2025 respectively.